PRISX
Price
$42.55
Change
-$0.01 (-0.02%)
Updated
Sep 18 closing price
RYKIX
Price
$97.36
Change
+$0.24 (+0.25%)
Updated
Sep 18 closing price
Ad is loading...

PRISX vs RYKIX

Header iconPRISX vs RYKIX Comparison
Open Charts PRISX vs RYKIXBanner chart's image
T. Rowe Price Financial Services
Price$42.55
Change-$0.01 (-0.02%)
VolumeN/A
CapitalizationN/A
Rydex Banking I
Price$97.36
Change+$0.24 (+0.25%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PRISX vs RYKIX Comparison Chart
Loading...
VS
PRISX vs. RYKIX commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRISX is a Buy and RYKIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
PRISX has more cash in the bank: 1.51B vs. RYKIX (4.58M). PRISX pays higher dividends than RYKIX: PRISX (1.77) vs RYKIX (1.40). PRISX was incepted earlier than RYKIX: PRISX (28 years) vs RYKIX (26 years). RYKIX is a more actively managed with annual turnover of: 384.00 vs. PRISX (30.20). PRISX (2500) and RYKIX (2500) have matching initial minimum investment requirements. RYKIX (37.82) and PRISX (36.01) have marching annual gain over last year. PRISX return over 5 years is better than : 65.06 vs. RYKIX (33.61).
PRISXRYKIXPRISX / RYKIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years26 years-
Gain YTD20.39614.799138%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.51B4.58M32,976%
Annual Yield % from dividends1.771.40127%
Returns for 1 year36.0137.8295%
Returns for 3 years28.665.23548%
Returns for 5 years65.0633.61194%
Returns for 10 years118.8567.44176%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSSC40.310.89
+2.26%
NAPCO Security Technologies
ALLK0.560.01
+1.30%
Allakos
LANC179.580.27
+0.15%
Lancaster Colony Corp
ALDX5.78-0.13
-2.20%
Aldeyra Therapeutics
TRI168.02-4.90
-2.83%
Thomson Reuters Corp